Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cediranib and chemo combo improves PFS for metastatic cervical cancer

Dr Raymond 'Paul' Symonds - University Hospital of Leicester, Leicester, UK
Cediranib and chemo combo improves PFS for metastatic cervical cancer ( Dr Raymond 'Paul' Symonds - University Hospital of Leicester, Leicester, UK )
28 Sep 2014

Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer

Dr Sandra Swain - Washington Cancer Institute, Washington, USA
Pertuzumab adds 16 months survival benefit to trastuzumab plus chemotherapy for HER2-positive metastatic breast cancer ( Dr Sandra Swain - Washington Cancer Institute, Washington, USA )
28 Sep 2014

Adding cediranib to chemo improves PFS for metastatic cervical cancer

Dr Paul Symonds - University Hospital of Leicester, Leicester, UK
Adding cediranib to chemo improves PFS for metastatic cervical cancer ( Dr Paul Symonds - University Hospital of Leicester, Leicester, UK )
28 Sep 2014

Reducing nausea and vomiting associated with cisplatin-based chemotherapy with rolapitant

Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South Africa
Reducing nausea and vomiting associated with cisplatin-based chemotherapy with rolapitant ( Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South Africa )
27 Sep 2014

The evolving treatment landscape for HER2-positive metastatic breast cancer

Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium
The evolving treatment landscape for HER2-positive metastatic breast cancer ( Dr Hatem Azim - Institut Jules Bordet, Brussels, Belgium )
18 Sep 2014

Navigating current treatment options for HER2-positive MBC: Patient journey 1

Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria
Navigating current treatment options for HER2-positive MBC: Patient journey 1 ( Dr Rupert Bartsch - Medical University of Vienna, Vienna, Austria )
18 Sep 2014

Overview of skin cancer treatments, past, present and future

Prof John Hawk - President of the World Congress on Cancers of the Skin 2014
Overview of skin cancer treatments, past, present and future ( Prof John Hawk - President of the World Congress on Cancers of the Skin 2014 )
11 Sep 2014

Advances in CLL: Expert panel Discussion

Prof Robin Foà ; Prof Clemens Wendtner; Dr Francesc Bosch; Prof Florence Cymbalista
Advances in CLL: Expert panel Discussion ( Prof Robin Foà ; Prof Clemens Wendtner; Dr Francesc Bosch; Prof Florence Cymbalista )
11 Sep 2014

Emerging treatments in CLL: Expert Discussion

Prof Robin Foà and Prof Peter Hillmen
Emerging treatments in CLL: Expert Discussion ( Prof Robin Foà and Prof Peter Hillmen )
11 Sep 2014

Melanoma live: Making patient-focused therapy decisions

Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long
Melanoma live: Making patient-focused therapy decisions ( Prof Dirk Schadendorf; Dr Paul Nathan; Prof Georgina Long )
1 Aug 2014

Repurposing generics to fight cancer and the work of the ReDO Project

Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium
Repurposing generics to fight cancer and the work of the ReDO Project ( Dr Gauthier Bouche - Anticancer Fund, Strombeek-Bever, Belgium )
10 Jul 2014

Looking for biomarkers in metronomic chemotherapy

Prof Guido Bocci - University of Pisa, Pisa, Italy
Looking for biomarkers in metronomic chemotherapy ( Prof Guido Bocci - University of Pisa, Pisa, Italy )
10 Jul 2014